Xcout Intel
RyboDyn competitors & alternatives
The 12 closest competitors and alternatives to RyboDyn among drug discovery companies — ranked by similarity to what RyboDyn actually does, not by market-cap band.
Subscribe to see RyboDyn’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About RyboDyn
RyboDyn is a biotechnology company that uses its proprietary RyboCypher platform, combining RNA sequencing and AI, to decode the dark proteome and identify hidden cancer targets. The company develops next-generation, antibody-based immunotherapies designed to address critical unmet needs in cancer treatment.
RyboDyn at a glance
RyboDyn is a drug discovery company. It has raised at least $14M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $10M in March 2026. Xcout tracks 9 named people at RyboDyn, including IMAD AJJAWI (Co-Founder & Chief Executive Officer).
RyboDyn leadership
- IMAD AJJAWICo-Founder & Chief Executive Officer
- COREY DAMBACHERFounder, President, & Chief Technology Officer
- KERRY WILSONCo-Founder & VP, Platform Development
- ASHLEY WOODFINCo-Founder & Bioinformatics Lead - Target Discovery
- ANDY BASSVP, Corporate Strategy
- ARIEL SCHWARTZVP, AI
3 more named people on record for RyboDyn, with roles, board committees and tenure — see the full roster →
RyboDyn funding rounds
At least $14M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $10M | 2 named | |
| Seed | $4M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 RyboDyn competitors
Ranked by semantic similarity — how close each company is to RyboDyn by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Similar drug discovery company
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Similar drug discovery company
Coding Bio is an Oxford-based biotechnology company that combines a high-throughput wet lab and machine learning platform to screen, build, and deliver fully-assembled modular therapies like CARs and BiTEs.
Similar drug discovery company
Renasis Bio Ltd. is a stealth-mode private company headquartered in Rehovot, Israel, established in 2025. The firm is developing an AI-driven drug discovery platform focused on RNA-targeting small molecules to advance RNA druggability.
Similar drug discovery company
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Similar drug discovery company
QurieGen is a precision medicine company headquartered in Nijmegen, Netherlands, that uses single-cell AI to transform drug development and create treatments more efficiently.
Similar drug discovery company
Mabsoft Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapeutic solutions, including antibody-drug conjugates and immuno-stimulating antibody conjugates for solid tumors and infectious diseases. The company's pipeline features proprietary candidates such as the antibody-drug conjugate MST-168.
Similar drug discovery company
LyncBio Therapeutics is an innovative drug discovery and development company headquartered in Shanghai, China, with research facilities in Suzhou. The firm specializes in the advancement of antibody-drug conjugate (ADC) therapeutics.
Similar drug discovery company
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Similar drug discovery company
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Similar drug discovery company
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Similar drug discovery company
Albatroz Therapeutics is a pre-clinical stage biotechnology company based in Singapore that is developing first-in-class antibody therapeutics to protect the extracellular matrix and treat solid tumors.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of RyboDyn and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for RyboDynand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →